DLH Holdings Corp. (NASDAQ:DLHC – Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 42,648 shares, a decline of 34.9% from the September 30th total of 65,558 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average daily trading volume, of 12,181 shares, the short-interest ratio is currently 3.5 days.
Insiders Place Their Bets
In other news, major shareholder Mink Brook Asset Management Ll purchased 199,099 shares of the company’s stock in a transaction on Thursday, October 1st. The shares were purchased at an average cost of $3.70 per share, with a total value of $736,666.30. Following the completion of the transaction, the insider owned 893,421 shares of the company’s stock, valued at $3,305,657.70. The trade was a 28.68% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have acquired 213,067 shares of company stock worth $796,804 in the last 90 days. 12.80% of the stock is currently owned by insiders.
Hedge Funds Weigh In On DLH
A hedge fund recently bought a new stake in DLH stock. Bank of New York Mellon Corp acquired a new stake in DLH Holdings Corp. (NASDAQ:DLHC – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,738 shares of the business services provider’s stock, valued at approximately $62,000. Bank of New York Mellon Corp owned 0.08% of DLH at the end of the most recent reporting period. Institutional investors and hedge funds own 67.25% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Zacks Research upgraded shares of DLH from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 29th. Noble Financial reiterated an “outperform” rating on shares of DLH in a research note on Friday, July 31st. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of DLH in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.
Get Our Latest Stock Report on DLHC
DLH Stock Down 3.8%
DLHC stock opened at $3.51 on Wednesday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.13. The firm has a market capitalization of $50.86 million, a PE ratio of -2.37 and a beta of 1.44. DLH has a 1-year low of $3.38 and a 1-year high of $6.88. The business’s 50 day simple moving average is $3.94 and its 200 day simple moving average is $5.15.
DLH Company Profile
DLH Holdings Corp. (NASDAQ: DLHC) provides healthcare, logistics and human services solutions primarily to the U.S. federal government. The company supports agencies and programs in areas such as public health, clinical research, population health, behavioral health, medical readiness and healthcare delivery.
DLH’s services include program management, health and human services support, data and analytics, information technology, medical logistics and supply-chain management. Its work supports federal healthcare and research programs, as well as military and veteran health initiatives, including activities associated with the Department of Veterans Affairs, the Department of Defense and agencies within the Department of Health and Human Services.
The company serves customers throughout the United States and may support government operations in deployed or other specialized environments.
Featured Articles
- Five stocks we like better than DLH
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for DLH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DLH and related companies with MarketBeat.com's FREE daily email newsletter.
